AB1044 Evaluation of a fluoroenzyme immunoassay (ELIA-CTD) in the screening of patients suspected for autoimmune connective tissue diseases

@article{Elkhalifa2017AB1044EO,
  title={AB1044 Evaluation of a fluoroenzyme immunoassay (ELIA-CTD) in the screening of patients suspected for autoimmune connective tissue diseases},
  author={M. Elkhalifa and R. Abdulhadi and H. Ramadan and S. Barrientos and S. Saleh and O. Alsaed and A. Al-Allaf},
  journal={Annals of the Rheumatic Diseases},
  year={2017},
  volume={76},
  pages={1420 - 1420}
}
Background Detection of auto-antibodies directed against nuclear antigens (antinuclear antibodies or ANA) have important diagnostic and prognostic implications in connective tissue diseases (CTD). The conventional indirect immunofluorescence assay on HEp-2 cell line (ANA-IIF) is the most commonly used method to detect ANA. The ANA-IIF can be labor intensive and suffers from lack of specificity. Objectives To evaluate the utility of a new fluoroenzyme Immunoassay “EliA-CTD” as an alternative for… Expand